GlassScriptPhysician profile
Mirela Draganescu
NPI 1932135696
$6,400.36
in general payments reported to CMS, 2019-2025
45 companies · $1,858 in 2025
The $1,858 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,979 · 2020: $1,503 · 2021: $12.50 · 2022: $145 · 2023: $314 · 2024: $588 · 2025: $1,858.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,760.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $818.58 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $769.70 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $693.08 | 2019-2025 | |
| Astellas Pharma US INC | $410.56 | 2019-2025 | Veozah |
| Abbvie INC. | $403.32 | 2020-2025 | Ubrelvy, Qulipta |
| Lilly USA, LLC | $358.09 | 2019-2025 | Mounjaro, Zepbound, Kisunla |
| Kowa Pharmaceuticals America, INC. | $330.04 | 2019-2025 | Zoryve, Livalo, Seglentis |
| Glaxosmithkline, LLC. | $294.55 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Allergan, INC. | $216.28 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $204.74 | 2019 | |
| Merck Sharp & Dohme LLC | $181.35 | 2019-2020 | |
| Amgen INC. | $163.35 | 2019-2020 | |
| Daiichi Sankyo INC. | $153.74 | 2019-2020 | |
| Exact Sciences Corporation | $128.59 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amarin Pharma, INC. | $122.93 | 2019-2020 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mirela Draganescu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.